DEPLOYDatabase

Company

Galen Robotics

Baltimore-based surgical robotics company developing the Galen ES robotic surgical assistant platform, the first cooperatively powered robotic surgical system…

HQ
Baltimore, MD, USA

Models

1

Overview

Baltimore-based surgical robotics company developing the Galen ES robotic surgical assistant platform, the first cooperatively powered robotic surgical system for ear, nose, and throat (ENT) procedures. Spun out of Johns Hopkins University, Galen received FDA De Novo clearance for ENT surgeries. The company uses a digital-surgery-as-a-service business model — placing robots at hospitals and charging per use rather than upfront capital purchase. Relocated from Silicon Valley to Baltimore in 2019 with state and city incentives.

Verified record

Verified deployments
None on file
Active incidents
None on file

DEPLOY Intelligence

Market intelligence for physical AI

Analyst-grade signals, competitive tracking, and investment context across the global physical AI landscape. Launching 2026.

Key facts

CEO

Bruce Lichorowic (President & CEO)

Product

Galen ES — cooperatively powered robotic surgical assistant for ENT

FDA clearance

De Novo clearance — first ENT surgical robot

Total funding

$26.1M ($15M Series A oversubscribed + $500K TEDCO seed + earlier rounds)

Business model

Digital-surgery-as-a-service — per-usage, not upfront hospital purchase

Origin

Johns Hopkins University spin-out

Financial stage

Growth — FDA cleared, deploying with RaaS model

Current leadership (1)

Safety record

No incidents on record for Galen Robotics.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Full safety record: incidents, sourcing, and exposure data →

Recent coverage

Galen Robotics in third-party press